Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

By Langdon Grant   Gueorguieva Ivelina   Aarons Leon   Karlsson Mats  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 485-498

Springer Publishing Company

Access to resources Recommend Favorite

Reducing Whole Body Physiologically Based Pharmacokinetic Models Using Global Sensitivity Analysis: Diazepam Case Study

By Gueorguieva Ivelina   Nestorov Ivan   Rowland Malcolm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 1, 2006-02 ,pp. : 1-27

Springer Publishing Company

Access to resources Recommend Favorite

Whole body physiologically-based pharmacokinetic models: their use in clinical drug development

By Edginton Andrea N   Theil Frank-Peter   Schmitt Walter   Willmann Stefan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1143-1152

Informa Healthcare

Access to resources Recommend Favorite

Assessment of interaction potential of AZD2066 using in vitro metabolism tools, physiologically based pharmacokinetic modelling and in vivo cocktail data

By Nordmark Anna   Andersson Anita   Baranczewski Pawel   Wanag Ewa   Ståhle Lars  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 167-178

Springer Publishing Company

Access to resources Recommend Favorite

Development of a Whole Body Physiologically Based Model to Characterise the Pharmacokinetics of Benzodiazepines. 1: Estimation of Rat Tissue-Plasma Partition Ratios

By Gueorguieva Ivelina   Nestorov Ivan A.   Murby Susan   Gisbert Sophie   Collins Brent   Dickens Kelly   Duffy Judith   Hussain Ziad   Rowland Malcolm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 4, 2004-08 ,pp. : 269-298

Springer Publishing Company

Access to resources Recommend Favorite